87 related articles for article (PubMed ID: 22927901)
1. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line.
Sun J; Yeung CA; Co NN; Tsang TY; Yau E; Luo K; Wu P; Wa JC; Fung KP; Kwok TT; Liu F
PLoS One; 2012; 7(8):e40720. PubMed ID: 22927901
[TBL] [Abstract][Full Text] [Related]
2. miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.
Zou Z; Zou R; Zong D; Shi Y; Chen J; Huang J; Zhu J; Chen L; Bao X; Liu Y; Liu W; Huang W; Hu J; Chen Z; Lao X; Chen C; Huang X; Lu Y; Ni X; Fang D; Wu D; Lu S; Jiang M; Qiu C; Wu Y; Qiu Q; Dong Y; Su Y; Zhao C; Zhong Z; Cai J; Liang Y
J Cell Mol Med; 2017 Sep; 21(9):1929-1943. PubMed ID: 28411377
[TBL] [Abstract][Full Text] [Related]
3. Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance.
Xu Y; Ohms SJ; Li Z; Wang Q; Gong G; Hu Y; Mao Z; Shannon MF; Fan JY
PLoS One; 2013; 8(11):e82062. PubMed ID: 24303078
[TBL] [Abstract][Full Text] [Related]
4. MDR1, cholesterol certification and cell growth: a comparative study in normal and multidrug-resistant KB cell lines.
Pani A; Batetta B; Putzolu M; Sanna F; Spano O; Piras S; Mulas MF; Bonatesta RR; Amat di S Filippo C; Vargiu L; Marceddu T; Sanna L; La Colla P; Dessì S
Cell Mol Life Sci; 2000 Jul; 57(7):1094-102. PubMed ID: 10961345
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of rpS3 by Lyn increases translation of Multi-Drug Resistance (MDR1) gene.
Ahn WS; Kim HD; Kim TS; Ahn MJ; Park YJ; Kim J
BMB Rep; 2023 May; 56(5):302-307. PubMed ID: 36724904
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein Mediates Postoperative Peritoneal Adhesion Formation by Enhancing Phosphorylation of the Chloride Channel-3.
Deng L; Li Q; Lin G; Huang D; Zeng X; Wang X; Li P; Jin X; Zhang H; Li C; Chen L; Wang L; Huang S; Shao H; Xu B; Mao J
Theranostics; 2016; 6(2):204-18. PubMed ID: 26877779
[TBL] [Abstract][Full Text] [Related]
7. Natural Inhibitors of P-glycoprotein in Acute Myeloid Leukemia.
Labbozzetta M; Poma P; Notarbartolo M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835550
[TBL] [Abstract][Full Text] [Related]
8. Development of Polymersomes Co-Delivering Doxorubicin and Melittin to Overcome Multidrug Resistance.
Han E; Kim D; Cho Y; Lee S; Kim J; Kim H
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770754
[TBL] [Abstract][Full Text] [Related]
9. Research Progress on Natural Diterpenoids in Reversing Multidrug Resistance.
Deng ZF; Bakunina I; Yu H; Han J; Dömling A; Ferreira MU; Zhang JY
Front Pharmacol; 2022; 13():815603. PubMed ID: 35418870
[TBL] [Abstract][Full Text] [Related]
10. Suppression Of Aberrant Activation Of NF-κB Pathway In Drug-resistant Leukemia Stem Cells Contributes To Parthenolide-potentiated Reversal Of Drug Resistance In Leukemia.
Yi J; Wang L; Wang XY; Sun J; Yin XY; Hou JX; Chen J; Xie B; Wei HL
J Cancer; 2021; 12(18):5519-5529. PubMed ID: 34405014
[TBL] [Abstract][Full Text] [Related]
11. Mycomedicine: A Unique Class of Natural Products with Potent Anti-tumour Bioactivities.
Dai R; Liu M; Nik Nabil WN; Xi Z; Xu H
Molecules; 2021 Feb; 26(4):. PubMed ID: 33669877
[TBL] [Abstract][Full Text] [Related]
12. Phytochemicals: Potential Lead Molecules for MDR Reversal.
Tinoush B; Shirdel I; Wink M
Front Pharmacol; 2020; 11():832. PubMed ID: 32636741
[TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin Sensitizes Mutant p53 (R248Q)-Expressing Hepatocellular Carcinoma Cells to Doxorubicin by Inhibiting P-gp Expression.
Yang Y; He J; Chen J; Lin L; Liu Y; Zhou C; Su Y; Wei H
Biomed Res Int; 2019; 2019():8207056. PubMed ID: 31976328
[TBL] [Abstract][Full Text] [Related]
14. Long Non-coding RNA KCNQ1OT1 Contributes to Antiepileptic Drug Resistance Through the miR-138-5p/ABCB1 Axis
Xie Y; Wang M; Shao Y; Deng X; Chen Y
Front Neurosci; 2019; 13():1358. PubMed ID: 31920517
[TBL] [Abstract][Full Text] [Related]
15. Folate-Gold-Bilirubin Nanoconjugate Induces Apoptotic Death in Multidrug-Resistant Oral Carcinoma Cells.
Rathinaraj P; Muthusamy G; Prasad NR; Gunaseelan S; Kim B; Zhu S
Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):285-296. PubMed ID: 31858458
[TBL] [Abstract][Full Text] [Related]
16. OCT4 Potentiates Radio-Resistance and Migration Activity of Rectal Cancer Cells by Improving Epithelial-Mesenchymal Transition in a ZEB1 Dependent Manner.
Shao M; Bi T; Ding W; Yu C; Jiang C; Yang H; Sun X; Yang M
Biomed Res Int; 2018; 2018():3424956. PubMed ID: 30112378
[TBL] [Abstract][Full Text] [Related]
17. Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.
Kadioglu O; Cao J; Kosyakova N; Mrasek K; Liehr T; Efferth T
Sci Rep; 2016 Nov; 6():36754. PubMed ID: 27824156
[TBL] [Abstract][Full Text] [Related]
18. Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1.
Wang C; Huo X; Wang L; Meng Q; Liu Z; Liu Q; Sun H; Sun P; Peng J; Liu K
Sci Rep; 2016 Jun; 6():28403. PubMed ID: 27329817
[TBL] [Abstract][Full Text] [Related]
19. NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells.
Abd Ellah NH; Taylor L; Ayres N; Elmahdy MM; Fetih GN; Jones HN; Ibrahim EA; Pauletti GM
Cancer Gene Ther; 2016 May; 23(5):149-55. PubMed ID: 27125866
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells.
Seubwai W; Vaeteewoottacharn K; Kraiklang R; Umezawa K; Okada S; Wongkham S
Oncol Res; 2016 Jan; 23(1-2):21-8. PubMed ID: 26802647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
